Genetic or pharmacological inhibition of AURKA significantly inhibited GSK3β S9 phosphorylation in pancreatic cancer cells, suggesting that GSK3β might indeed act as a downstream target of AURKA in necroptosis. The gene discussed is AURKA; the disease is pancreatic neoplasm.